---
title: "Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Effects of other drugs"
description: "Formulary evidence on Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Effects of other drugs. Topics: Immunoprophylaxis schedule and taper in the trial protocols, Vaccination required before the immunosuppression regimen, and Pre-existing anti-AAV9 antibodies in the nonclinical studies. 3 evidence topics quoted from 3 sources."
canonical: "https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description/effects-of-other-drugs"
published: "2026-11-15T20:23:41-05:00"
modified: "2026-11-15T20:23:41-05:00"
---

# Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Effects of other drugs

<a id="heading-2.1.2.9.1"></a>

## 2.1.2.9.1 Effects of Other Drugs on Lonimecgene renparvovec

<a id="topic-2.1.2.9.1-1"></a>

### Immunoprophylaxis schedule and taper in the trial protocols

> “Immunoprophylaxis will begin at Day –7 and will be tapered from Week 17 to Week 25 (oral prednisolone) and starting from Week 38 (sirolimus).”

Source: [Devidze et al. (2023)](https://tayshagtx.com/wp-content/uploads/Design-of-the-REVEAL-Pediatric-study-of-TSHA-102-gene-therapy-for-Rett-Syndrome.pdf)

<a id="topic-2.1.2.9.1-2"></a>

### Vaccination required before the immunosuppression regimen

> “Participant must be up to date with all relevant local vaccination requirements, with last vaccination dose received at least 42 days prior to the start of the immunosuppression regimen.”
> “Participant has contraindications for IT administration of TSHA-102 or lumbar puncture procedure, other medical conditions, or contraindications to any medications required for IT administration.”

Source: [ClinicalTrials.gov NCT06152237](https://clinicaltrials.gov/study/NCT06152237)

<a id="topic-2.1.2.9.1-3"></a>

### Pre-existing anti-AAV9 antibodies in the nonclinical studies

> “Serum AAV9 neutralizing (nAb) antibodies, were assessed before treatment. Animals with detectable nAbs (e.g., titers ≥1:10) were preferentially chosen for diluent-only treatment, whereas those with low or undetectable nAbs could receive rAAV9 treatment.”

Source: [Haque et al. (2026a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13167494/)

<a id="topic-2.1.2.9.1-4"></a>

### Clinical pharmacokinetic drug interaction studies

No evidence found.

## Related pages
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Terms and abbreviations](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations.md)
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Product information and disease description](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Clinical evidence](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Economic information and modeling report](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: References](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references.md)
